1 |
Avanir Pharmaceuticals Inc. v. Ranbaxy Laboratories Limited et al |
1:14-cv-00792 |
D.Del. |
|
|
|
|
2 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
3 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
4 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
5 |
Forest Laboratories Inc. et al v Ranbaxy Inc. et al |
1:13-cv-01607 |
D.Del. |
|
|
|
|
6 |
Forest Laboratories Inc. et al v Ranbaxy Inc. et al |
1:13-cv-01607 |
D.Del. |
|
|
|
|
7 |
Forest Laboratories Inc. et al v Ranbaxy Inc. et al |
1:13-cv-01607 |
D.Del. |
|
|
|
|
8 |
Acura Pharmaceuticals Inc. v. Ranbaxy Inc. et al |
1:13-cv-00750 |
D.Del. |
|
|
|
|
9 |
WARNER CHILCOTT COMPANY, LLC et al v. RANBAXY, INC. et al |
2:12-cv-02474 |
D.N.J. |
|
|
|
|
10 |
WARNER CHILCOTT COMPANY, LLC et al v. RANBAXY, INC. et al |
2:12-cv-02474 |
D.N.J. |
|
|
|
|
11 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
12 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
13 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
14 |
Lupin Atlantis Holdings SA v. Ranbaxy Laboratories Limited et al |
1:10-cv-00659 |
D.Del. |
|
|
|
|
15 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
16 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
17 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
18 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
19 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
20 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
21 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
22 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
23 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
24 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
25 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
26 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
27 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
28 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
29 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
30 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
31 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
32 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
33 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
34 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
35 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|